Metallomix
Miami, US · Founded 2021 · Florida corporation
Find your way into Metallomix
A clinical-stage biotech company developing novel drugs based on isotope-selective modulation technology, with patented drug compositions and a proprietary development platform currently in clinical trials.
Founders & leadership
Metallomix was founded in 2021 by Max Temnik, PhD.
MT
Max Temnik, PhDFounder, President
MT
Max TemnikinExecutive
SG
Sergey Gurin, MBAExecutive Vice President
SK
Santosh Kesari, MD, PhDChief Medical Officer, U.S.
SP
Sergei PetukhovNamed on SEC filing
SG
Sergey GurinNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$2.1M disclosed across 4 rounds · 2021
▶$1.2MraisedNov 2025 · 1 investors · BiotechnologyRule 506(b)
▶$1.2MraisedNov 2025 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Sergei PetukhovExecutive Officer, Director
- Max TemnikExecutive Officer
- Sergey GurinExecutive Officer, Director
- Offering amount
- $10M
- Amount sold
- $1.2M
- Minimum investment
- $1M
- First sale
- Oct 2021
- Incorporated
- Corporation, Florida, 2021
- Federal exemptions
- 06b
▶$534.2KraisedSep 2023 · 1 investors · BiotechnologyRule 506(b)
▶$534.2KraisedSep 2023 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Max TemnikExecutive Officer
- Offering amount
- $10M
- Amount sold
- $534.2K
- Minimum investment
- $1M
- First sale
- Oct 2021
- Incorporated
- Corporation, Florida, 2021
- Federal exemptions
- 06b
▶$300KraisedMay 2022 · 1 investors · BiotechnologyRule 506(b)
▶$300KraisedMay 2022 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Max TemnikExecutive Officer
- Offering amount
- $10M
- Amount sold
- $300K
- Minimum investment
- $1M
- First sale
- Oct 2021
- Incorporated
- Corporation, Florida, 2021
- Federal exemptions
- 06b
▶$100KraisedNov 2021 · 1 investors · BiotechnologyRule 506(b)
▶$100KraisedNov 2021 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Max TemnikExecutive Officer
- Offering amount
- $100K
- Amount sold
- $100K
- First sale
- Oct 2021
- Incorporated
- Corporation, Florida, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 6
by search overlap
Phenomix Sciences7 shared keywordsPhenomix Sciences applies data analytics and patient data to enable precision obesity medicine, aiming to guide treatment decisions for anti-obesity medications such as GLP-1s and reduce care costs. Its platform-based approach targets the healthcare market for obesity treatment.
Logomix5 shared keywordsGenome engineering-based drug discovery and biomanufacturing R&D support.
BiomX4 shared keywordsBiomX builds a portfolio of defense and security companies through subsidiaries, partnerships, and acquisitions, focusing on detection systems, aerial technologies, and infrastructure security. It targets field-proven products serving homeland security, critical infrastructure, border, transportation, and public safety needs within a Detection, Analysis, and Response operational chain.
Rsc4 shared keywordsThe Royal Society of Chemistry is a professional membership organisation that connects the global chemistry community through partnerships, conferences, networks and publications. It sets standards for chemical scientists, promotes open access to scientific knowledge, and advocates for chemistry's role in addressing societal challenges including healthcare, environmental protection, and clean energy.
Tenomix4 shared keywordsTenomix develops intelligent automation technology for cancer diagnostics and healthcare labs to improve diagnostic speed and accuracy while addressing staffing shortages and rising patient caseloads. The company works with clinical partners across North America, embedding automation into existing lab workflows.
Romix Biosciences3 shared keywordsRomix Bio develops technology to generate deeper insights into disease biology and therapeutic activity. The page provides minimal detail about its specific products or offerings.
Companies competing with Metallomix for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Metallomix do?
- A clinical-stage biotech company developing novel drugs based on isotope-selective modulation technology, with patented drug compositions and a proprietary development platform currently in clinical trials.
- Who founded Metallomix?
- Metallomix was founded by Max Temnik, PhD in 2021.
- How much funding has Metallomix raised?
- Metallomix has disclosed $2.1M raised across 4 rounds.
- Where is Metallomix headquartered?
- Metallomix is headquartered in Miami, US.